You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Toward Hijacking Bioelectricity in Cancer to Develop New Bioelectronic Medicine
Contributor:
Robinson, Andie J.;
Jain, Akhil;
Sherman, Harry G.;
Hague, Richard J. M.;
Rahman, Ruman;
Sanjuan‐Alberte, Paola;
Rawson, Frankie J.
Published:
Wiley, 2021
Published in:
Advanced Therapeutics, 4 (2021) 3
Language:
English
DOI:
10.1002/adtp.202000248
ISSN:
2366-3987
Origination:
Footnote:
Description:
AbstractBioelectronic medicine is a treatment modality that uses electricity to treat disease by altering the body's electrical communication systems. All cells are electrically active, in that they possess bioelectric circuitry generating a resting membrane potential and endogenous electric fields that influence cell functions and communication. There is now an accepted paradigm that cancer is characterized by malfunctions in cells’ bioelectrical circuitry. This yields opportunities for bioelectronic medicine as novel treatments for cancer by manipulating its bioelectrical properties. To highlight the possibilities a bioelectrical approach can offer cancer therapy, the relevance of bioelectrical activity in cancer is reviewed and also how such activity can be hijacked in novel treatments. This includes sensing or measuring the electrical activity of cells for diagnostic and prognostic applications, controlling or altering bioelectricity including both ionic and faradaic current processes, and eliciting morphological changes using electric fields. Importantly, key links between cellular ionic and faradaic processes that contribute to cancer phenotypes are presented, which if considered and understood as a whole, can bring broad‐reaching improvements to cancer therapy.